1-20 of 70
Tatyana Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Polygenic HLA-Class I and HLA-Class II Models Define Various Types of Lymphoma

Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy
Journal: Blood
Blood (2023) 142 (Supplement 1): 6110.
https://doi.org/10.1182/blood-2023-187686
Published: 2023
Journal Articles

Lymphoma Diagnosis and Classification Using Next Generation Sequencing of 30 CD Markers and Machine Learning As an Alternative to Immunohistochemistry

Maher Albitar, Hong Zhang, Andrew Ip, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy
Journal: Blood
Blood (2023) 142 (Supplement 1): 3665.
https://doi.org/10.1182/blood-2023-187534
Published: 2023
Journal Articles

Phase 1 Study of Autologous Sirpα-Low Macrophages (SIRPant-M) Administered By Intratumoral Injection Alone or in Combination with External-Beam Radiotherapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma (NCT05967416)

Paolo Strati, Tatyana Feldman, Christiane Querfeld, Salvia Jain, Nathanael McCurley, Rita Bàrcia, Koby Kidder, Jelle Kylstra
Journal: Blood
Blood (2023) 142 (Supplement 1): 4856.
https://doi.org/10.1182/blood-2023-175040
Published: 2023
Journal Articles

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States

Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin Nassar, Elio Adib, Noha Abdel-Wahab, Nikita Chintapally, Claire E. Drolen, Tatyana Feldman, Tarek Haykal, Caroline A. Nebhan, Swetha Kambhampati, Mingjia Li, Arjun Mittra, Michael Lorentsen, Chul Kim, Alexandra Drakaki, Michael Morse, Douglas B. Johnson, Ankit Mangla, Chris Dittus, Praful Ravi, Paul G. Rubinstein, Sarvari V. Yellapragada, Ann LaCasce, Guru P. Sonpavde, Abdul Rafeh Naqash, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 3071.
https://doi.org/10.1182/blood-2023-174589
Published: 2023
Journal Articles

PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL

Swami P. Iyer, Neha Mehta-Shah, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Frank Morschhauser, EVA Domingo Domenech, Chiara Pagani, Won Seog Kim, Onder Alpdogan, Cheolwon Suh, Tatyana Feldman, Hervé Tilly, Pier Luigi Zinzani, Alessandro Rambaldi, David Belada, Jiri Mayer, Ilseung Choi, June-Won Cheong, Shweta Jain, Fenton Keenan, Michelle A. Fanale, Kerry J. Savage, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3074.
https://doi.org/10.1182/blood-2023-184933
Published: 2023
Journal Articles

Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1

Julie M. Vose, Tatyana Feldman, Martine E.D. Chamuleau, Won Seog Kim, Pieternella Lugtenburg, Tae Min Kim, Pau Abrisqueta Costa, Chan Y. Cheah, Ingrid Cecilia Glimelius, Brian Hess, Wojciech Jurczak, Gerardo Musuraca, Adam J. Olszewski, Minh Dinh, Nurgul Kilavuz, Monica Wielgos-Bonvallet, Tommy Li, Zhu Li, Christian Eskelund, Umar Farooq
Journal: Blood
Blood (2023) 142 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2023-180333
Published: 2023
Journal Articles

Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multi-Center Retrospective Analysis

Eleanor Taranto, Wei-Ting Hwang, Maria Alfaro, Annika S Surapaneni, Sarvarinder Kaur Gill, Tatyana Feldman, Michael P Randall, Michael A Spinner, Fateeha Furqan, Nirav N. Shah, Yazeed Samara, Matthew G. Mei, Alex F. Herrera, Alison Moskowitz, Gunjan L. Shah, Jakub Svoboda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2023-187199
Published: 2023
Journal Articles

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

Eric Jacobsen, Dai Maruyama, Pierluigi Porcu, Kensei Tobinai, Pamela B. Allen, Kenji Ishitsuka, Kunihiro Tsukasaki, Shigeru Kusumoto, Francine M. Foss, Nobuhiko Yamauchi, Satoko Morishima, Yoshitaka Imaizumi, Koji Izutsu, Tatyana Feldman, Toyotaka Kawamata, Yasuyuki Kakurai, Hideyuki Yamauchi, Noha Biserna, Ai Inoue, Shinji Tsutsumi, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 303.
https://doi.org/10.1182/blood-2023-172512
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced Stage Classical Hodgkin Lymphoma: Efficacy and Safety Results from the Single Arm Phase 2 Study

Hun Ju Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte A. Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Scott Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Chris Yasenchak
Journal: Blood
Blood (2023) 142 (Supplement 1): 608.
https://doi.org/10.1182/blood-2023-173972
Published: 2023
Journal Articles

Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Aditi Shastri, Eric J Feldman, Alexander N Starodub, Tatyana Feldman, Cristina P Rodriguez, Zachary D. Epstein-Peterson, Don A. Stevens, Adam J Olszewski, Auris O Huen, Pierluigi Porcu, John C Reneau, Stefan K. Barta, Enrica Marchi, Ahmad H Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Sean Donohue, Joyoti Dey, Sagar Agarwal, Rahul Karnik, Ashwin Gollerkeri, Jared Gollob, Stephen D Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 3081.
https://doi.org/10.1182/blood-2023-181130
Published: 2023
Journal Articles

Retrospective Review of Patients Treated with Intrathecal Rituximab for Primary and Secondary CNS Lymphoma and Leukemia

Tatyana Feldman, Alexandra Della Pia, Geeny Lee, Thomas S. Gunning, Michael Pelliccia, Tony Varughese, Harsh Parmar, Andrew Ip, Lori A. Leslie, Andre Goy, Samuel Singer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2023-187164
Published: 2023
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in R/R CLL/SLL: 24-Month Median Follow-up of TRANSCEND CLL 004

Tanya Siddiqi, David G Maloney, Saad S. Kenderian, Danielle M Brander, Kathleen Dorritie, Jacob Soumerai, Peter A Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San-San Ou, Neha Rane, William G. Wierda
Journal: Blood
Blood (2023) 142 (Supplement 1): 330.
https://doi.org/10.1182/blood-2023-179529
Published: 2023
Journal Articles

Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)

Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Journal: Blood
Blood (2022) 140 (Supplement 1): 11893–11895.
https://doi.org/10.1182/blood-2022-169586
Published: 2022
Journal Articles

Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma

Steven I. Park, Stephen M. Ansell, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, Elizabeth L. Budde, Andrew J Ness, Yunsik Choi, Philip J Bierman, Hun Ju Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 1751–1752.
https://doi.org/10.1182/blood-2022-159258
Published: 2022
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)

Hun Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Christopher A. Yasenchak
Journal: Blood
Blood (2022) 140 (Supplement 1): 763–765.
https://doi.org/10.1182/blood-2022-156553
Published: 2022
Journal Articles

Liquid Immunophenotyping and the Diagnosis of Lymphoid Neoplasms Using Cell-Free RNA

Maher Albitar, Hong Zhang, Andrew Ip, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Ipsa Sharma, Andrew L. Pecora, Lori Leslie, Tatyana Feldman, Andre H. Goy
Journal: Blood
Blood (2022) 140 (Supplement 1): 7828–7829.
https://doi.org/10.1182/blood-2022-162590
Published: 2022
Journal Articles

A Phase 1 Study of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Stephen D Smith, Alexander Starodub, Don A. Stevens, Aditi Shastri, Pierluigi Porcu, Tatyana Feldman, Reggie Ewesuedo, Chris DeSavi, Joyoti Dey, Sagar Agarwal, Sean Donohue, Rachelle Perea, Christine Klaus, Jared Gollob
Journal: Blood
Blood (2022) 140 (Supplement 1): 12024–12025.
https://doi.org/10.1182/blood-2022-169514
Published: 2022
Journal Articles

Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

David J. Straus, MD, Monika Dlugosz-Danecka, MD PhD, Joseph M. Connors, MD, Árpád Illés, MD PhD, Marco Picardi, MD, Ewa Lech-Marańda, MD PhD, Tatyana Feldman, Piotr Smolewski, MD PhD, Kerry J. Savage, MDMSc, Nancy L. Bartlett, MD, Jan Walewski, MD, Radhakrishnan Ramchandren, MD, Pier Luigi Zinzani, MD, Martin Hutchings, MD PhD, Javier Munoz, MD, Won Seog Kim, MD PhD, Ranjana Advani, MD, Stephen M. Ansell, MD PhD, Anas Younes, Andrea Gallamini, Rachael Liu, PhD, Meredith Little, MPH, Keenan Fenton, Michelle A. Fanale, MD, John A. Radford, MD FMedSci
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–28.
https://doi.org/10.1182/blood-2020-137089
Published: 2020
Journal Articles

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

Clinical Trials & Observations
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Joseph M. Connors, John Radford, Javier Munoz, Won Seog Kim, Ranjana Advani, Stephen M. Ansell, Anas Younes, Harry Miao, Rachael Liu, Keenan Fenton, Andres Forero-Torres, Andrea Gallamini
Journal: Blood
Blood (2020) 135 (10): 735–742.
https://doi.org/10.1182/blood.2019003127
Published: 2020
Includes: Supplemental data
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, MD, Jeremy S. Abramson, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Oliver W Press, MD PhD, Timothy S. Fenske, MD, Jonathan Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, Gaurav Gupta, MD PhD, Randy D Gascoyne, MD, Elaine Jaffe, MD
Journal: Blood
Blood (2016) 128 (22): 4145.
https://doi.org/10.1182/blood.V128.22.4145.4145
Published: 2016